Originally published on LinkedIn. Novartis Pharmaceuticals is a Fair360, formerly DiversityInc Hall of Fame company.
“We are not just discoverers. We actually create molecules that have never been made before.” Says Karin Briner, Head of Global Discovery Chemistry at Novartis Institutes for BioMedical Research (NIBR). By collaborating with Microsoft and augmenting the expertise of our chemists with AI, we hope to discover and develop promising molecules faster.
To learn more about Novartis and Microsoft’s partnership, click here
